We are pleased to share the following independent educational offerings from our corporate sponsors.
The Hidden Threat: Nonadherence and Noncompliance Non-Valvular AF Patient
Nonadherence and noncompliance are two of the most common causes of treatment failure for NVAF patients. This expert-led peer-to-peer discussion from faculty specializing in heart and brain will offer you a unique lens into their approaches to address this complex phenomenon based on the latest clinical evidence and real-world experience.
- Is Nonadherence and Noncompliance Diagnosable and Treatable?
- Patient vs Physician Perspective on Risk Benefit Assessment
- Identifying the Barrier to Suit Patient Need
- Importance of Monitoring
Manisha Shah, MD | David Z Rose, MD | Ian Del Conde, MD, FACC, FSVM
Practical Management of Anticoagulation for Impella Percutaneous Mechanical Circulatory Support
- Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
- Allison Burnett, PharmD, PhC, CACP
- Doug Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
From our corporate sponsor Medtronic, we are pleased to share this 1-hour educational session on:
Cardiac Monitoring for Data-guided Atrial Fibrillation Management
Featuring William E. Dager, Pharm.D., BCPS, MCCM, FASHP, FACCP, FCSHP & David S. Frankel, M.D., FACC, FHRS discussing cardiac monitoring strategies for data-guided decisions in the management of atrial fibrillation including anticoagulation and antiarrhythmic decisions. The goal of this educational session is to increase the attendee’s understanding of the interaction between drugs, devices, and patients in the management of atrial fibrillation through case study discussions.